“…Due to its lipophilicity, B[a]P is readily absorbed through biological membranes and undergoes bioactivation to reactive metabolites mediated by enzymes from the Cytochrome P450 (CYP) superfamily, including cytochrome P450 1A1 (CYP1A1), cytochrome P450 1A2 (CYP1A2), and cytochrome P450 1B1 (CYP1B1), resulting in the production of ROS and metabolites such as phenol forms, epoxides, dihydrodiols, dihydrodiol epoxides, and anti-7,8-dihydroxy-9,10-epoxy-7,8,9,10-tetrahydro-B[a]P [30,32,35,38,44,45]. It has been demonstrated that the production of B[a]P-7,8-epoxide, mediated by CYP1A1, and its subsequent transformation to B[a]P-trans-7,8-dihydrodiol (B[a]P-7,8-DHD) in the presence of epoxide hydrolase represent dangerous reactions, as B[a]P-7,8-DHD is converted to the carcinogenic metabolite 7β,8α-dihydroxy-9α,10α-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene (BPDE), which creates DNA adducts, causing mutations and malignant transformations [35,46].…”